WorldQuant Millennium Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-91,693
Closed -$33.8M 445
2024
Q4
$33.8M Buy
+91,693
New +$38.4M 0.22% 127
2024
Q1
Sell
-29,704
Closed -$14M 368
2023
Q4
$14M Sell
29,704
-106,831
-78% -$49.4M 0.2% 143
2023
Q3
$59.5M Buy
136,535
+115,023
+535% +$52.2M 0.92% 15
2023
Q2
$9.56M Sell
21,512
-14,649
-41% -$6.76M 0.16% 179
2023
Q1
$16.6M Buy
+36,161
New +$17.2M 0.31% 106
2022
Q1
Sell
-59,630
Closed -$27.6M 312
2021
Q4
$27.6M Buy
+59,630
New +$25.1M 0.55% 55
2021
Q2
Sell
-62,709
Closed -$22.5M 356
2021
Q1
$22.5M Sell
62,709
-14,821
-19% -$4.77M 0.48% 61
2020
Q4
$24.9M Sell
77,530
-10,752
-12% -$3.3M 0.54% 45
2020
Q3
$23.7M Buy
88,282
+739
+0.8% +$199K 0.56% 42
2020
Q2
$23M Buy
87,543
+7,821
+10% +$2.09M 0.53% 45
2020
Q1
$18.1M Buy
79,722
+5,300
+7% +$1.44M 0.44% 69
2019
Q4
$22.5M Buy
+74,422
New +$20.5M 0.43% 89

Other funds holding ELV

WorldQuant Millennium Advisors's ELV Position: Q1 2025 in Review

WorldQuant Millennium Advisors sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 91,693 shares — an estimated $33.8M sold.

WorldQuant Millennium Advisors first reported a position in ELV in Q4 2019 and held it in 12 quarters. The position peaked at $59.5M in Q3 2023. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • WorldQuant Millennium Advisors reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • WorldQuant Millennium Advisors sold 91,693 Elevance Health shares in Q1 2025, an estimated $33.8M.
  • WorldQuant Millennium Advisors first reported a position in Elevance Health in Q4 2019 and held it in 12 quarters.
  • WorldQuant Millennium Advisors's Elevance Health position peaked at $59.5M in Q3 2023.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on WorldQuant Millennium Advisors's 13F filing for Q1 2025, filed 15 May 2025.